Relenza (zanamivir) — CareFirst (Caremark)
Treatment or prophylaxis of influenza A or B viral infection
Preferred products
- Tamiflu (oseltamivir)
Initial criteria
- Authorization may be granted when the requested drug is being prescribed for prophylaxis of influenza A or B viral infection in a patient age ≥ 5 years during a community outbreak OR for treatment or prophylaxis of influenza A or B viral infection
Approval duration
3 months